8-K
filed June 10, 2026, 5:19 PM ET
ticker FENC
CIK 0001211583
other
confidence high
sentiment neutral
materiality 0.15
Fennec shareholders approve all proposals at 2026 annual meeting
FENNEC PHARMACEUTICALS INC.
- All five director nominees elected: Islam, Rallis, Brughera, Cook, Hackman with ~20M+ votes each.
- Haskell & White LLP ratified as auditor: 26,091,716 for, 134,491 withheld, 29,165 against.
- Advisory vote on executive compensation approved: 19,326,750 for, 336,060 against.
- Advisory frequency set to every year: 18,235,648 for one year, minimal votes for other intervals.
- Amendments to 2020 Equity Incentive Plan and adoption of 2026 Equity Inducement Plan approved.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
FENNEC PHARMACEUTICALS INC. shareholders approved Advisory vote on the frequency of advisory votes on compensation at the 2026-06-10 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
The resolution to vote on the advisory vote on the frequency of advisory votes on compensation of Corporations named executive officers was approved based on the following vote: Votes For Evey One Year 18,235,648 Votes For Evey Two Years 2,326 Votes For Evey Three Years 2,086219 Abstentions 49,294
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
FENNEC PHARMACEUTICALS INC. shareholders approved Ratification and adoption of Fennec's 2026 Equity Inducement Plan at the 2026-06-10 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
The resolution to ratify and approve the adoption of Fennec’s 2026 Equity Inducement Plan was approved based on the following vote:. Votes For 18,626,207 Votes Against 1,033,779 Abstentions 713,501 Broker Non-Votes 5,881,885
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
FENNEC PHARMACEUTICALS INC. shareholders approved Election of five nominees to serve as directors at the 2026-06-10 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
The following five (5) nominees were elected to serve as directors
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
FENNEC PHARMACEUTICALS INC. shareholders approved Appointment of Haskell & White LLP as independent public accounting firm and authorization to fix remuneration at the 2026-06-10 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
The resolution to appoint Haskell & White LLP as independent public accounting firm of the Company and to authorize the Board of Directors to fix their remuneration was approved based on the following vote: Votes For 26,091,716 Votes Withheld 134,491 Votes Against 29,165 Broker Non-Votes 0
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
FENNEC PHARMACEUTICALS INC. shareholders approved Advisory vote on executive compensation at the 2026-06-10 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
The resolution to vote on the advisory vote on executive compensation was approved based on the following vote: Votes For 19,326,750 Votes Against 336,060 Abstentions 710,677 Broker Non-Votes 5,881,885
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
FENNEC PHARMACEUTICALS INC. shareholders approved Approval of amendments to Corporation's 2020 Equity Incentive Plan at the 2026-06-10 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2026-06-10
Exact text from the filing
The resolution to approve certain amendments to Corporation’s 2020 Equity Incentive Plan was approved based on the following vote: Votes For (1) 17,425,439 Votes Against 1,429,951 Abstentions 751,944 Broker Non-Votes 5,881,885
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.